These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37806387)

  • 41. Efficacy, efficiency and safety aspects of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems.
    Fu TY; Gent P; Kumar V
    J Hosp Infect; 2012 Mar; 80(3):199-205. PubMed ID: 22306442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engaging patients in the prevention of health care-associated infections: a survey of patients' awareness, knowledge, and perceptions regarding the risks and consequences of infection with methicillin-resistant Staphylococcus aureus and Clostridium difficile.
    Ottum A; Sethi AK; Jacobs E; Zerbel S; Gaines ME; Safdar N
    Am J Infect Control; 2013 Apr; 41(4):322-6. PubMed ID: 22884494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Multicenter Randomized Trial to Determine the Effect of an Environmental Disinfection Intervention on the Incidence of Healthcare-Associated Clostridium difficile Infection.
    Ray AJ; Deshpande A; Fertelli D; Sitzlar BM; Thota P; Sankar C T; Jencson AL; Cadnum JL; Salata RA; Watkins RR; Sethi AK; Carling PC; Wilson BM; Donskey CJ
    Infect Control Hosp Epidemiol; 2017 Jul; 38(7):777-783. PubMed ID: 28462761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms.
    Nerandzic MM; Cadnum JL; Pultz MJ; Donskey CJ
    BMC Infect Dis; 2010 Jul; 10():197. PubMed ID: 20615229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Québec: Impact of Guidelines.
    Li L; Fortin E; Tremblay C; Ngenda-Muadi M; Garenc C; Moisan D; Villeneuve J; Quach C;
    Infect Control Hosp Epidemiol; 2017 Jul; 38(7):840-847. PubMed ID: 28580894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.
    Dai W; Yang T; Yan L; Niu S; Zhang C; Sun J; Wang Z; Xia Y
    BMC Infect Dis; 2020 Apr; 20(1):277. PubMed ID: 32293302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.
    Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S
    BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic review of the effectiveness of cohorting to reduce transmission of healthcare-associated
    Abad CL; Barker AK; Safdar N
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):691-709. PubMed ID: 32216852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of laboratory-identified event surveillance to classify adverse outcomes due to
    Shen Y; Ellison J; Leal J; Bush KR; Chandran AU; Fathima S; Conly JM
    Infect Control Hosp Epidemiol; 2021 May; 42(5):557-564. PubMed ID: 33222722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can Emergency Department Wait Times Predict Rates of Hospital-Acquired Clostridioides difficile Infection? A Study of Acute Care Facilities in New York State.
    Durant DJ; Young CG
    J Patient Saf; 2022 Mar; 18(2):e508-e513. PubMed ID: 34009865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review and meta-analysis of decontamination methods to prevent hospital environmental contamination and transmission of Clostridioidesdifficile.
    Kato H; Hagihara M; Asai N; Shibata Y; Yamagishi Y; Iwamoto T; Mikamo H
    Anaerobe; 2022 Feb; 73():102478. PubMed ID: 34808391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hospital-acquired Clostridioides difficile infections in Alberta: The validity of laboratory-identified event surveillance versus clinical infection surveillance.
    Almond J; Leal J; Bush K; Rogers E; Henderson EA; Ellison J
    Am J Infect Control; 2020 Jun; 48(6):633-637. PubMed ID: 31733811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of pulsed xenon ultraviolet light on hospital-acquired infection rates in a community hospital.
    Vianna PG; Dale CR; Simmons S; Stibich M; Licitra CM
    Am J Infect Control; 2016 Mar; 44(3):299-303. PubMed ID: 26684369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating different concentrations of hydrogen peroxide in an automated room disinfection system.
    Murdoch LE; Bailey L; Banham E; Watson F; Adams NM; Chewins J
    Lett Appl Microbiol; 2016 Sep; 63(3):178-82. PubMed ID: 27324207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members.
    Khanafer NL; Fitzpatrick F; Barbut F; Krutova M; Davies K; Guery B; Vanhems P
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):785-789. PubMed ID: 38332395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of deep cleaning followed by hydrogen peroxide decontamination during high Clostridium difficile infection incidence.
    Best EL; Parnell P; Thirkell G; Verity P; Copland M; Else P; Denton M; Hobson RP; Wilcox MH
    J Hosp Infect; 2014 May; 87(1):25-33. PubMed ID: 24746230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms.
    Passaretti CL; Otter JA; Reich NG; Myers J; Shepard J; Ross T; Carroll KC; Lipsett P; Perl TM
    Clin Infect Dis; 2013 Jan; 56(1):27-35. PubMed ID: 23042972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of Infection due to Clostridium (Clostridioides) difficile.
    Krishna A; Chopra T
    Infect Dis Clin North Am; 2021 Dec; 35(4):995-1011. PubMed ID: 34752229
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rethinking
    Skally M; Bennett K; Humphreys H; Fitzpatrick F
    Euro Surveill; 2024 Feb; 29(6):. PubMed ID: 38333935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Healthcare associated
    Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
    Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.